{"id":382833,"date":"2020-11-17T08:04:14","date_gmt":"2020-11-17T13:04:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382833"},"modified":"2020-11-17T08:04:14","modified_gmt":"2020-11-17T13:04:14","slug":"healthlynked-reports-59-year-to-date-and-74-quarterly-year-over-year-revenue-growth-along-with-positive-shareholders-equity-of-352k-for-first-time-in-companys-history","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/healthlynked-reports-59-year-to-date-and-74-quarterly-year-over-year-revenue-growth-along-with-positive-shareholders-equity-of-352k-for-first-time-in-companys-history\/","title":{"rendered":"HealthLynked Reports 59% Year-to-Date and 74% Quarterly Year-Over-Year Revenue Growth along with Positive Shareholders’ Equity of $352k For First Time in Company’s History"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NAPLES, Fla.<\/span>, Nov. 17, 2020<\/span> \/PRNewswire\/ —\u00a0HealthLynked Corp. <\/b>(OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients and medical data, late Monday reported its financial results for the three and nine months ended September 30, 2020<\/span>. Year-to-date 2020 results included a 59% increase in revenue and a 14% decrease in operating loss compared to the same period of 2019.\u00a0 Third quarter 2020 revenue also increased 74% compared to third quarter 2019.\u00a0\u00a0\u00a0<\/p>\n

During September 2020<\/span>, the Company’s accountable care organization (ACO) subsidiary Cura Health Management, acquired in May 2020<\/span>, received a revenue determination of $767,744<\/span> from the Center for Medicare Services (CMS) for ACO shared savings revenue for program year 2019.\u00a0 The Company also realized a 23% increase in patient service revenue on a year-to-date basis compared to the same period of 2019.\u00a0 <\/p>\n

HealthLynked reported positive shareholders’ equity of $351,818<\/span> as of September 30, 2020<\/span>, compared to a shareholders’ deficit of ($2,842,680)<\/span> for the period ending December 31, 2019<\/span>. The improvement was due in large part to a $3 million<\/span> equity investment from the Company’s Chairman and CEO, Dr. Michael Dent<\/span>, in August 2020<\/span>. <\/p>\n

\n
\n Year-to-Date 2020 Compared to 2019:<\/u>
\n <\/b>\n <\/p>\n